We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

58 hedge funds and large institutions have $16M invested in Anixa Biosciences in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more call options, than puts

Call options by funds: $122K | Put options by funds: $71K

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

18% more capital invested

Capital invested by funds: $13.6M → $16M (+$2.48M)

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

2% more funds holding

Funds holding: 57 → 58 (+1)

0.74% less ownership

Funds ownership: 18.15% → 17.41% (-0.74%)

Holders
58
Holders Change
+1
Holders Change %
+1.75%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
11
Reduced
7
Closed
7
Calls
$122K
Puts
$71K
Net Calls
+$51K
Net Calls Change
-$88K

Top Buyers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
+$217K
2
KAS
Kestra Advisory Services
Texas
+$51.5K
3
SG Americas Securities
SG Americas Securities
New York
+$44.4K
4
LPL Financial
LPL Financial
California
+$40K
5
BlackRock
BlackRock
New York
+$35.4K

Top Sellers

Rank Fund Capital Flow
1
LFCM
Long Focus Capital Management
Puerto Rico
-$342K
2
Citadel Advisors
Citadel Advisors
Florida
-$251K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$247K
4
DADC
D.A. Davidson & Co
Montana
-$162K
5
EGM
Engineers Gate Manager
New York
-$41.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
NFG
26
Nations Financial Group
Iowa
$64.3K – – –
Renaissance Technologies
27
Renaissance Technologies
New York
$61.4K +$19.7K +6,900 +47%
RSWM
28
Robertson Stephens Wealth Management
California
$44.8K – – –
KeyBank National Association
29
KeyBank National Association
Ohio
$44.4K – – –
SG Americas Securities
30
SG Americas Securities
New York
$44K +$44.4K +15,514 New
DWM
31
Dakota Wealth Management
Florida
$42.9K – – –
SW
32
Simplicity Wealth
New Jersey
$40K – – –
Group One Trading
33
Group One Trading
Illinois
$38.3K +$32.7K +11,431 +588%
HighTower Advisors
34
HighTower Advisors
Illinois
$37.6K -$209 -73 -0.6%
CAM
35
Concorde Asset Management
Michigan
$37.6K – – –
Charles Schwab
36
Charles Schwab
California
$36.6K – – –
PAG
37
Private Advisor Group
New Jersey
$35.4K +$35.4K +12,364 New
SJGA
38
Stephen J. Garry & Associates
New York
$28.8K – – –
SCA
39
STALEY CAPITAL ADVISERS
Pennsylvania
$28.6K – – –
Wells Fargo
40
Wells Fargo
California
$24.3K – – –
PNC Financial Services Group
41
PNC Financial Services Group
Pennsylvania
$8.69K – – –
MCM
42
MAI Capital Management
Ohio
$7.92K -$429 -150 -5%
AA
43
Ancora Advisors
Ohio
$4.35K – – –
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$3K – – –
CWM
45
Crowley Wealth Management
Delaware
$2.86K – – –
SC
46
Stephens Consulting
Michigan
$2.86K – – –
PS
47
Principal Securities
Iowa
$2.32K – – –
FDCDDQ
48
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.72K +$1.72K +600 New
LFG
49
Larson Financial Group
Missouri
$1.43K – – –
PCC
50
Park Circle Company
Maryland
$1.43K – – –
1
2
3

ANIX Hedge Fund Activity: Q1 2025 in Review

58 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q1 2025, worth a combined $16M — up 18% from $13.6M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ANIX positions and 7 closed out — a net gain of 1 holder — while 11 added to existing stakes and 7 trimmed.

The largest buyer was GSA Capital Partners, opening a new position worth an estimated $217K. The largest seller was Long Focus Capital Management, exiting entirely with an estimated $342K sold.

  • 58 institutional investors held Anixa Biosciences (ANIX) as of Q1 2025, up from 57 in Q4 2024.
  • Funds reported $16M of Anixa Biosciences stock for Q1 2025, up 18% quarter-over-quarter.
  • 8 funds opened new Anixa Biosciences positions in Q1 2025 and 7 closed out, a net change of +1 holder.
  • The largest Anixa Biosciences buyer in Q1 2025 was GSA Capital Partners, an estimated $217K added.
  • The largest Anixa Biosciences seller in Q1 2025 was Long Focus Capital Management, an estimated $342K sold.

Based on aggregated 13F filings for Q1 2025.